Scientists to test drugs for 3 autism-related conditions

12/4/2008 | MIT Technology Review

Researchers plan to conduct human trials of three medications to explore their potential in treating rare, genetic disorders associated with autism -- fragile X, Rett syndrome and tuberous sclerosis complex. One of the studies will test whether chemically triggering a pathway called insulin-like growth factor in Rett syndrome patients is effective at inducing undeveloped synapses to mature.

View Full Article in:

MIT Technology Review

Published in Brief:

SmartBrief Job Listings for Education

Job Title Company Location
K-12 Teachers Needed at Int’l Schools
The International Educator
Multiple Locations
Assistant Professor of Education with Math and/or Science (STEM) Emphasis
Dean, School of Education
Syracuse University
Syracuse, NY
Math Specialist
PCG Education
Richmond, VA
Instructional Design Specialist
Insight Education Group
Encino, CA